Staphylococcal superantigen-like protein 5 induces thrombotic and bleeding complicationsin vivo: inhibition by an anti-SSL5 antibody and the glycan Bimosiamose

Targeting the Platelet Integrin GPIIb/IIIa

(2011) Christoph E. Hagemeyer et al.   CURRENT PHARMACEUTICAL DESIGN

GPVI and GPIbα Mediate Staphylococcal Superantigen-Like Protein 5 (SSL5) Induced Platelet Activation and Direct toward Glycans as Potential Inhibitors

(2011) Houyuan Hu et al.   PLoS One

Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation

(2010) T. Takemitsu et al.   THROMBOSIS AND HAEMOSTASIS

Guidelines for the diagnosis and management of disseminated intravascular coagulation

(2009) M Levi et al.   BRITISH JOURNAL OF HAEMATOLOGY

Staphylococcal superantigen-like 5 activates platelets and supports platelet adhesion under flow conditions, which involves glycoprotein Ibα and αIIbβ3

(2009) C. J. C. DE HAAS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Staphylococcal SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins

(2008) J. Bestebroer et al.   BLOOD